As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxycholorquine, prove to be a possible prophylactic? Newt talks with Dr. David Pearce of Sanford Health. Sanford Health is conducting the first controlled hydroxycholoquine clinical trial in the United States.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Episode 1040: Profit from the Profit — Why Most Investors Are Actually Speculating
37:41

Episode 1039: 25 Years After 911 — Confronting the Next Generation of Threats
33:09

Episode 1038: The Global War on God — Dr. Hak Ja Han and the Fight for Religious Liberty
56:39